A Non-intervention Trial of the Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer)
Phase of Trial: Phase IV
Latest Information Update: 05 Mar 2016
At a glance
- Drugs Iron isomaltoside 1000 (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- Acronyms WAVE
- Sponsors Pharmacosmos
- 01 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Aug 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Jul 2015 to 1 Nov 2015.
- 18 Aug 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Apr 2015 to 1 Nov 2015.